Tikcro Technologies (TIKRF) Stock Price, News & Analysis

Company Overview

Tikcro Technologies Ltd. operates as a biopharmaceutical company. It pursues an early stage biotechnology project generating new antibodies for cancer treatment addressing immune modulation. This project is based on technology from the Weizmann Institute of Science in Israel. It promotes a new approach for the generation of antibodies which are expected to have selectivity and blocking capabilities and, as a result, are expected to effectively modulate the immune system. Tikcro Technologies was founded on December 14, 1999 and is headquartered in Hadera, Israel.

Key Stats

• Today's Range: $0.28 to $0.28
• 50-Day Range: $0.28 to $0.28
• 52-Week Range: $0.11 to $0.30
• Volume: N/A
• Average Volume: 17,800 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TIKRF Stock Analysis - Frequently Asked Questions

How have TIKRF shares performed this year?

Tikcro Technologies' stock was trading at $0.28 at the beginning of 2025. Since then, TIKRF stock has increased by 0.0% and is now trading at $0.28.
View the best growth stocks for 2025 here.

How do I buy shares of Tikcro Technologies?

Shares of TIKRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: Internet Software & Services
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:TIKRF
• CIK: 1117095
• Web: tikcro.com
• Phone: (724) 671-5933
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A